VAXZEVRIA (previously COVID-19 Vaccine AstraZeneca) ChAdOx1-S solution for injection multidose vial (349072)

Approved for Supply while noncompliant with standards. The consent is effective from 15 February 2021 until 15 February 2023.

Approved for Import and supply while noncompliant with standards. The consent is effective for all batches manufactured utilising the ‘UK labels’ for 8 doses per vial, imported and supplied in Australia from 25 February 2021 until 15 February 2023.

Approved for Supply while noncompliant with standards. The consent is for all batches manufactured utilising the ‘AU labels’ for 10 doses per vial that will be supplied in Australia. The consent is effective from 21 March 2021 until 15 February 2023.